Ribosomal protein L7a pseudogene 42 (RPL7AP42)

Ribosomal protein L7a pseudogene 42 (RPL7AP42) is a processed pseudogene in the human genome that has high sequence similarity to the functional RPL7A gene, which encodes the ribosomal protein L7a, a component of the large (60S) ribosomal subunit involved in catalyzing protein synthesis. RPL7AP42 itself does not code for a functional protein and is generally not transcribed or translated in normal biology. Unlike the protein-coding RPL7A gene, RPL7AP42 is considered part of the non-functional genomic background and does not have established roles in cellular biology, disease, or as a therapeutic target[1][5][16]. RPL7AP42 is classified as a pseudogene, meaning it is a segment of DNA resembling a gene but is non-functional and does not produce a protein product[1][5][16]. The functional gene, RPL7A, encodes a ribosomal protein that participates in the 60S ribosomal subunit important for protein synthesis, but none of these functions are attributable to RPL7AP42[4][7]. There is no evidence in current scientific literature that this pseudogene acts as a receptor, enzyme, transporter, or is otherwise therapeutically "druggable"; thus, it is not considered a therapeutic target[1][5][16]. There are no known pharmacological agents, biomarkers, or biological functions directly linked to RPL7AP42. The presence of the pseudogene can be relevant for genomic studies or in distinguishing it from similar functional genes (e.g., in mutational or expression analysis of RPL7A), but not for therapeutic development or disease mechanism. In summary, Ribosomal protein L7a pseudogene 42 (RPL7AP42) is a human pseudogene with no known protein product, biological function, disease relevance, drug interactions, or role as a therapeutic target[1][5][16].

Other names

RPL7A_19_836RPL7AP42